CoChat

Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA

Lu, Mei, Zhao, Xiaoyun, Xing, Haonan, Xun, Zhe, Zhu, Shimeng, Lang, Lang, Yang, Tianzhi, Cai, Cuifang, Wang, Dongkai, Ding, Pingtian · 2018 · International Journal of Pharmaceutics
Cited by 151

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Graphical abstract Figure. No Caption available. Abstract Exosomes have been extensively explored as delivery vehicles due to low immunogenicity, efficient cargo delivery, and possibly intrinsic homing capacity. However, therapeutic application of exosomes is hampered by structural complexity and lack of efficient techniques for isolation and drug loading. Liposomes represent one of the most successful therapeutic nanocarriers, but are frequently criticized by short blood circulation and inefficient intracellular drug delivery. In this circumstance, a promising strategy is to facilitate a positive feedback between two fields. Herein, exosome‐mimicking liposomes were formulated with DOPC/SM/Chol/DOPS/DOPE (21/17.5/30/14/17.5, mol/mol), and harnessed for delivery of VEGF siRNA to A549 and HUVEC cells. Compared with Lipo 2000 and DOTAP liposomes, exosome‐mimicking liposomes exhibited less than four‐fold cytotoxicity but higher storage stability and anti‐serum aggregation effect. Exosome‐mimicking liposomes appeared to enter A549 cells through membrane fusion, caveolae‐mediated endocytosis, and macropinocytosis, while enter HUVEC through caveolae‐mediated endocytosis, which revealed that the uptake pathway was dependent on cell types. Notably, exosome‐mimicking liposomes exhibited significantly higher cellular uptake and silencing efficiency than PC‐Chol liposomes (>three‐fold), suggesting the unique lipid composition did enhance the intracellular delivery efficiency of exosome‐mimicking liposomes to a significantly greater extent. However, it still remained far from satisfactory delivery as compared to cationic Lipo 2000 and DOTAP liposomes, which warranted further improvement in future research. This study may encourage further pursuit of more exosome‐mimicking delivery vehicles with higher efficiency and biocompatibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2018.08.040

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 151

Metadata

Authors
Lu, M., Zhao, X., Xing, H., Xun, Z., Zhu, S., Lang, L., Yang, T., Cai, C., Wang, D., & Ding, P.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2018-10
Volume
550
Issue
1-2
Pages
100-113
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2888206234
Cited by
151
References
10
FWCI
4.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.08.040
The paper
Lu, M., Zhao, X., Xing, H., Xun, Z., Zhu, S., Lang, L., Yang, T., Cai, C., Wang, D., & Ding, P. (2018). Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.08.040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.